HiRes Optima™ Sound Processing From Advanced Bionics Corporation Receives Worldwide Approval

VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that it received FDA, Health Canada and TÜV approval for the global distribution of HiRes Optima™* sound processing. The world’s newest sound strategy for cochlear implant recipients, HiRes Optima delivers optimized battery life with the same great performance as AB’s patented HiRes Fidelity 120™* processing. AB cochlear implant recipients using this new technology enjoy an average improvement of 55% in battery life, giving them considerably more time to hear their world before needing to change a battery.